PPC
DXCM icon

Park Place Capital’s DexCom DXCM Stock Holding History

Park Place Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.45K Hold
66
– – ﹤0.01% 943
2026
Q1 		$4.14K Buy
66
+25
+61% +$1.74K ﹤0.01% 700
2025
Q4 		$2.72K Buy
+41
New +$2.65K ﹤0.01% 689
2025
Q3 		– Sell
-844
Closed -$70.5K – 798
2025
Q2 		$70.5K Hold
844
– – 0.02% 300
2025
Q1 		$57.6K Sell
844
-24
-3% -$1.96K 0.02% 330
2024
Q4 		$67.5K Buy
868
+844
+3,517% +$62.5K 0.02% 321
2024
Q3 		$1.61K Hold
24
– – ﹤0.01% 795
2024
Q2 		$2.72K Sell
24
-216
-90% -$27.3K ﹤0.01% 747
2024
Q1 		$33.3K Hold
240
– – 0.01% 460
2023
Q4 		$29.8K Sell
240
-1,434
-86% -$146K 0.01% 476
2023
Q3 		$156K Sell
1,674
-272
-14% -$30.7K 0.05% 272
2023
Q2 		$250K Buy
1,946
+30
+2% +$3.63K 0.07% 217
2023
Q1 		$223K Buy
1,916
+2
+0.1% +$224 0.06% 232
2022
Q4 		$217K Buy
+1,914
New +$210K 0.06% 232

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Park Place Capital's DXCM Position: Q2 2026 in Review

Park Place Capital held its DexCom (DXCM) position steady in Q2 2026 at 66 shares worth $4.45K. The position accounts for ﹤0.01% of the portfolio, ranked #943.

Park Place Capital first reported a position in DXCM in Q4 2022 and has held it in 14 quarters since. The position peaked at $250K in Q2 2023. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Park Place Capital held 66 shares of DexCom worth $4.45K as of Q2 2026.
  • Park Place Capital left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #943 holding.
  • Park Place Capital first reported a position in DexCom in Q4 2022 and has held it in 14 quarters since.
  • Park Place Capital's DexCom position peaked at $250K in Q2 2023.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.